COLUMBUS 5-year update: a randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF

Future Oncology, Ahead of Print.

Source: Future Oncology - June 13, 2023 Category: Cancer & Oncology Authors: Reinhard Dummer Keith T Flaherty Caroline Robert Ana Arance Jan Willem B de Groot Claus Garbe Helen J Gogas Ralf Gutzmer Ivana Krajsov á Gabriella Liszkay Carmen Loquai Mario Mandal à Dirk Schadendorf Naoya Yamazaki Alessandra di Pietro Jean Cantey-Kise Source Type: research